Academic literature on the topic 'Maladies cardiovasculaires – Maladies'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Maladies cardiovasculaires – Maladies.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Maladies cardiovasculaires – Maladies":
Riediger, ND, SG Bruce, and TK Young. "Risque de maladies cardiovasculaires en fonction des profils plasmatiques d’apolipoprotéines et de lipides chez une communauté des Premières nations du Canada." Maladies chroniques au Canada 31, no. 1 (December 2010): 39–45. http://dx.doi.org/10.24095/hpcdp.31.1.06f.
Coly, Pierre-Michael, and Xavier Loyer. "Vésicules extracellulaires et maladies cardiovasculaires." médecine/sciences 37, no. 12 (December 2021): 1119–24. http://dx.doi.org/10.1051/medsci/2021204.
Nabi, H. "Place du stress dans le risque cardiovasculaire." European Psychiatry 28, S2 (November 2013): 38–39. http://dx.doi.org/10.1016/j.eurpsy.2013.09.097.
Tiret, Laurence. "Gene-environment interaction: a central concept in multifactorial diseases." Proceedings of the Nutrition Society 61, no. 4 (November 2002): 457–63. http://dx.doi.org/10.1079/pns2002178.
Vandestienne, Marie, Jérémie Joffre, Jérémie Lemarié, and Hafid Ait-Oufella. "Rôle du récepteur TREM-1 dans les maladies cardiovasculaires." médecine/sciences 38, no. 1 (January 2022): 32–37. http://dx.doi.org/10.1051/medsci/2021242.
Massoubre, C., A. Gay, and T. Sigaud. "Le malade complexe en psychiatrie de liaison : aspects thérapeutiques." European Psychiatry 29, S3 (November 2014): 588. http://dx.doi.org/10.1016/j.eurpsy.2014.09.302.
Pineault, R., S. Provost, M. Hamel, A. Couture, and JF Levesque. "L’influence des modèles d’organisation de soins de santé primaires sur l’expérience de soins de patients atteints de différentes maladies chroniques." Maladies chroniques et blessures au Canada 31, no. 3 (June 2011): 120–32. http://dx.doi.org/10.24095/hpcdp.31.3.05f.
Fagot, J. P., S. Samson, J. Merlière, P. Gabach, and A. Fagot. "L’association fréquente des pathologies somatiques aux troubles psychiatriques en population adulte, à travers les données de l’Assurance Maladie." European Psychiatry 28, S2 (November 2013): 87. http://dx.doi.org/10.1016/j.eurpsy.2013.09.233.
No Author. "Chapitre 2 : Maladies cardiovasculaires." Journal of Obstetrics and Gynaecology Canada 41 (June 2019): S49—S57. http://dx.doi.org/10.1016/j.jogc.2019.02.141.
Ferrières, J. "Nutrition et maladies cardiovasculaires." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2013, no. 214 (January 2013): 29. http://dx.doi.org/10.1016/s1261-694x(13)70457-7.
Dissertations / Theses on the topic "Maladies cardiovasculaires – Maladies":
Garnot, Delphine. "L'homocystéine dans les maladies cardiovasculaires." Paris 5, 1995. http://www.theses.fr/1995PA05P142.
Brand-Herrmann, Stefan-Martin. "Génétique des maladies cardiovasculaires." Paris 6, 2006. http://www.theses.fr/2006PA066503.
Kyndt, Florence. "Génétique des maladies cardiovasculaires dégénératives." Nantes, 2002. http://www.theses.fr/2002NANT02VS.
Boillot, Adrien. "Pathogènes parodontaux, marqueurs inflammatoires et maladies cardiovasculaires." Thesis, Université Paris-Saclay (ComUE), 2016. http://www.theses.fr/2016SACLV036/document.
Periodontitis is an inflammatory disease affecting tissues surrounding the teeth,and is caused by a dysregulation between periodontal pathogens and the host response.Numerous studies observed an association between periodontal pathogens, clinical signsof periodontitis, antobodies against periodontalpathogens, and cardiovascular events oratherosclerosis. The first cross-sectional studywas conducted among 457 adults aged 52+from ARIC cohort. We investigated therelationship between severe periodontitis andmodifications in the retinal microcirculation. Previous studies found increase in retinalvenular diameters predicted futurecardiovascular events. We observed asignificant and independent increase in retinalvenular diameters with severe periodontitis. Ina second cross-sectional study conductedamong 593 adults aged 55+ from INVESTcohort, we investigated the relationshipbetween the presence of periodontal pathogensand phospholipases A2 activities, enzymeswhich are associated with future cardiovascularevents. We observed participants with higherrelative concentrations of periodontalpathogens had higher secretory phospholipaseA2 activity. Future prospective studies areneeded to explore the impact of inflammatorymarkers and first microcirculatory alterations inthe association between periodontitis and futurecardiovascular events
Boileau, Adeline. "Biomarqueurs transcriptomiques sanguins des maladies cardiovasculaires." Thesis, Université de Lorraine, 2018. http://www.theses.fr/2018LORR0186/document.
Cardiovascular disease (CVD) is the main cause of mortality in the World and in Europe. Diagnosis and prediction of outcome of CVD currently rely on the use of protein biomarkers, but should be improved to optimize patient healthcare. Blood transcriptome contains all RNA molecules present in blood cells and in the acellular compartment. Among them, messenger RNA (mRNA) code for proteins whereas small non coding RNA, microRNA (miRNA), have a regulatory function by repressing the expression of their target genes. We hypothesized that blood transcriptome, mRNA and miRNA in particular, had a potential as biomarker, diagnostic or prognostic, in CVD. In a first study, we showed that endogenous heparin could lead to an inhibition of reverse transcription and quantitative PCR reaction used to measure miRNAs expressed in the blood, and that this parameter should be considered for studies on blood transcriptome. Secondly, we showed that 3 transcripts (coding for genes LMNB1, LTBP4, TGFBR1) expressed in whole blood, were independent predictors of cardiac function alteration at 4 months post-MI. Furthermore, the inclusion of these 3 transcripts in a prediction model containing clinical variables had an incremental predictive value. In a third study, we showed that circulating levels of miR-574-5p were able to discriminate patients with TAA from healthy controls. Furthermore, miR-574-5p was encapsulated in extracellular vesicles in the blood, suggesting a paracrine role. In the fourth and fifth studies, we showed that circulating levels of miR-122-5p were independent predictors of neurological outcome and survival at middle term post-CA, and were able to increase the prediction value of existing models. We also identified miR-574-5p as an independent predictor of neurological outcome post-CA, specifically in women. To conclude, this work allowed the discovery or the confirmation of the potential biomarker value of transcripts and miRNAs in different CVD. However, their biomarker value should be validated in other large scale studies and with other methods of measurement before foreseeing their clinical utilization
Le, Belleguy Pierre Daniel Alain Reboul Olivier. "Influences des parodontites sur les maladies cardiovasculaires." [S.l.] : [s.n.], 2003. http://theses.univ-nantes.fr/thesemed/CDlebelleguy.pdf.
Pallaud, Céline. "Détermination d'un profil génétique de risque cardiovasculaire : approche épidémiologique." Nancy 1, 2001. http://www.theses.fr/2001NAN12001.
Raingeard, Muriel Nazih-Sanderson Françoise. "Aliments santé et maladies cardiovasculaires les nouveaux ingrédients /." [S.l.] : [s.n.], 2006. http://theses.univ-nantes.fr/thesemed/PHraingeard.pdf.
Delmas-Marsalet, Béatrice. "Les complications cardio-vasculaires dans la maladie de hodgkin." Bordeaux 2, 1990. http://www.theses.fr/1990BOR23052.
Goretti, Emeline. "Les microARN : biomarqueurs et cibles thérapeuthiques des maladies cardiovasculaires." Thesis, Université de Lorraine, 2014. http://www.theses.fr/2014LORR0130/document.
Cardiovascular diseases are the leading cause of death in the world. Major issues in the management of these patients lie on the diagnosis and the prediction of the prognosis. MicroRNAs (miRNAs) are small single-stranded non-coding RNAs that inhibit gene expression. Circulating miRNAs appeared as potentials biomarkers of cardiovascular diseases. MicroRNAs could be also useful to stimulate cardiac repair. We hypothesized that miRNAs could be used as biomarkers of cardiovascular diseases, and also as therapeutic tools to improve cardiac repair after myocardial infarction. We evaluated the diagnostic capacity of miRNAs in patients with chest pain. MicroRNA-208b and miR-499 were potential diagnostic biomarkers in patients with myocardial infarction, without improving the diagnostic accuracy of traditional biomarkers. MicroRNA-423-5p predicted the rehospitalization of patients with acute heart failure and miR-21 and miR-122 are associated with neurological damage after cardiac arrest. Overall, our results indicate that circulating miRNAs could be useful diagnostic and prognostic biomarkers of cardiovascular diseases. We also showed that inhibiting miR-16 could stimulate the proliferation, differentiation and pro-angiogenic capacities of endothelial progenitor cells and that miR-150 is involved in the effect of adenosine on the recruitment of these cells after myocardial infarction. These results suggest that miRNAs could be used to improve the revascularization after myocardial infarction. In conclusion, our studies contributed to the characterization of several miRNAs, which clinical utility in the cardiovascular field remains to be confirmed
Books on the topic "Maladies cardiovasculaires – Maladies":
d'Encausse, Marina Carrère. Les maladies cardiovasculaires. [Paris]: Marabout, 2007.
Rackner, Vicki, and Renée Thivierge. Maladies cardiovasculaires: Faits importants, histoires inspirantes. Montréal: Sciences et culture, 2006.
Gibelin, Pierre. L' Éducation thérapeutique: Applications au maladies cardiovasculaires. Paris: Flammarion Médecine-Sciences, 2006.
Guignard, Jean-Pierre. Développement rénal et programmation des maladies cardiovasculaires. Paris: Elsevier, 2005.
Haïat, Robert. Thérapeutique cardiovasculaire: Lecture transversale des grands essais cliniques. 3rd ed. Paris: Frison-Roche, 2004.
Conférence internationale sur la santé cardiovasculaire (4e 2001 Osaka, Japon). Déclaration d'Osaka: Une intervention au niveau sanitaire, économique et politique : endiguer la lame de fond planétaire des maladies cardiovasculaires : déclaration du Comité consultatif de la quatrième Conférence internationale sur la santé cardiovasculaire, Osaka, Japon, mai 2001. Ottawa, Ont: Santé Canada, 2001.
Dubé, Richard. Problèmes cardiovasculaires: Nouvelles solutions naturelles. Montréal]: Éditions Cardinal, 2005.
Sassard, Thomas. Cardiologie: Lecture et interprétation de l'électrocardiogramme. Rueil-Malmaison: Pradel, 2007.
Dorosz, Philippe. Guide pratique des médicaments en cardiologie: 2005. Paris: Maloine, 2005.
Phillips, Bradley G. Drug information handbook for cardiology, 2000-2001. Hudson, Ohio: Lexi-Comp Inc., 2000.
Book chapters on the topic "Maladies cardiovasculaires – Maladies":
Montaigne, David, Pierre-Vladimir Ennezat, Stéphane Hatem, Rémi Nevière, and Benoît Vallet. "Maladies cardiovasculaires: anomalies des canaux calciques." In Maladies rares en réanimation, 37–43. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-287-99070-0_4.
Fontan, B., and O. Toulza. "Complications cardiovasculaires des inhibiteurs des cholinestérases." In Traité sur la maladie d’Alzheimer, 289–96. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0443-9_16.
Caquet, René. "Maladies cardiovasculaires." In Analyses De Laboratoire en Odontostomatologie, 29–52. Elsevier, 2012. http://dx.doi.org/10.1016/b978-2-294-71487-0.00003-1.
Arveiler, Dominique, and Aline Wagner. "55. Maladies cardiovasculaires." In Traité de santé publique, 515. Lavoisier, 2016. http://dx.doi.org/10.3917/lav.bourd.2016.01.0540.
Fredenrich, A. "Maladies cardiovasculaires, HTA, dyslipidémie." In Nutrition clinique pratique, 225–33. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-70931-9.00019-x.
Gaborit, B. "Obésité et maladies cardiovasculaires." In Les Obésités, 263–67. Elsevier, 2021. http://dx.doi.org/10.1016/b978-2-294-76753-1.00049-7.
"Mortalité due aux maladies cardiovasculaires." In Panorama de la santé 2009, 22–23. OECD, 2009. http://dx.doi.org/10.1787/health_glance-2009-6-fr.
"Mortalité due aux maladies cardiovasculaires." In Panorama de la santé 2011, 28–29. OECD, 2011. http://dx.doi.org/10.1787/health_glance-2011-6-fr.
"Mortalité due aux maladies cardiovasculaires." In Panorama de la santé 2013, 28–29. OECD, 2013. http://dx.doi.org/10.1787/health_glance-2013-7-fr.
"Mortalité due aux maladies cardiovasculaires." In Panorama de la santé 2019, 76–77. OECD, 2019. http://dx.doi.org/10.1787/20bcabf4-fr.